Q1 FY27 revenue up 153% YoY but profit dips 11%

Revenue growth above 20%EBITDA margin compressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹32.83

prior close

₹33.02

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.4% vs market

Commodity Chemicals peers, median of 54sector+0.0%+0.5% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+0.2+0.4+0.0+0.5

Next day

+11.9+0.2+11.6+0.4+11.5

+6.6+0.4+6.3-0.0+6.7

+0.5+0.7-0.2-0.8+1.3

+0.3+0.1+0.2-0.4+0.7

-2.2+0.7-2.9+0.9-3.1

-0.1+1.2-1.3+0.0-0.1

15d

-0.7+0.7-1.4+1.3-2.0

+0.5-1.2+1.7+0.3+0.2

+2.1-1.1+3.2+2.2-0.1

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pentokey Organy India reported Q1 FY27 revenue of Rs 209 lakh, up 153% from Rs 82.62 lakh in Q1 FY26. However, profit before tax fell to Rs 21.73 lakh from Rs 24.55 lakh, a decline of about 11%. EPS stood at Rs 0.35 versus Rs 0.39 earlier. The statutory auditor issued an unmodified limited review report. The company operates in the pharma and pesticides trading segment.

Likely market impact

Revenue tripled YoY but profit slipped, pointing to margin pressure. Small-cap with thin trading volumes.